R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The AI revolution in pharma

The pharmaceutical industry is at a pivotal moment. Artificial intelligence (AI) is shifting from improving processes to reshaping disease treatment and care delivery.

R&D

diverse path, arrows in three directions on ground

Diversity in STEM in 2024: A reflection and a path forward

In recent years, the fields of Science, Technology, Engineering, and Mathematics (STEM) have been the cornerstone of innovation and progress.

R&D

Where do we stand with clinical trial digitalisation?

Digitalisation is happening all around us, including in tech-enabled clinical research and development.

R&D

Quality compliance in the digital era

Quality compliance in the pharma industry is foundational to guaranteeing safe and effective products.

R&D

World Without Disease white paper feature image

World Without Disease initiative: 2024 update

In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year

R&D

How small molecule-focused CDMOs can navigate the impact of ...

As large-molecule drugs and weight-loss therapeutics dominate headlines, the pharmaceutical industry faces legislative pressures, funding cuts, and cascading supply chain disruptions.